{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:04:31Z","timestamp":1790705071509,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T00:00:00Z","timestamp":1531699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.anpedi.2017.10.012","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T12:58:34Z","timestamp":1512565114000},"page":"176-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["S\u00edndrome de West criptog\u00e9nico: perfil cl\u00ednico, respuesta al tratamiento y factores pron\u00f3sticos"],"prefix":"10.1016","volume":"89","author":[{"given":"Mar\u00eda","family":"Calder\u00f3n Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Arce Portillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"L\u00f3pez Lobato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Mu\u00f1oz Cabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara","family":"Blanco Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Madruga Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Alonso Luego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2017.10.012_bib0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.33588\/rn.5202.2010392","article-title":"S\u00edndrome de West: Etiolog\u00eda, opciones terap\u00e9uticas, evoluci\u00f3n cl\u00ednica y factores pron\u00f3sticos","volume":"52","author":"Arce","year":"2011","journal-title":"Rev Neurol"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0387-7604(01)00266-2","article-title":"West & son: The origins of West syndrome","volume":"23","author":"Lux","year":"2001","journal-title":"Brain Dev"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.seizure.2015.01.001","article-title":"Long-term outcomes in patients with West syndrome: An outpatient clinical study","volume":"25","author":"G\u00fc veli","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0170","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1528-1167.2010.02695.x","article-title":"The underlying etiology of infantile spasms (West syndrome): Information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification","volume":"51","author":"Osborne","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0175","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.seizure.2010.07.016","article-title":"Idiopathic West syndrome followed by childhood absence epilepsy","volume":"19","author":"Specchio","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0180","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/epi.12951","article-title":"How should children with West syndrome be efficiently and accurately investigated? Results from the National Infantile Spasms Consortium","volume":"56","author":"Wirrell","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0185","first-page":"1","article-title":"Infantile spasm: A review article","volume":"8","author":"Taghdiri","year":"2014","journal-title":"Iran J Child Neurol"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0190","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0195","first-page":"260","article-title":"Management of infantile spasms","volume":"4","author":"Nelson","year":"2015","journal-title":"Transl Pediatr"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0200","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.seizure.2010.01.008","article-title":"Treatment and long term outcome in West syndrome: The clinical reality. A multicentre follow up study","volume":"19","author":"Lagae","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0205","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1474-4422(05)70199-X","article-title":"The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: A multicentre randomised trial","volume":"4","author":"Lux","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0210","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(04)17400-X","article-title":"The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: A multicentre randomised controlled trial","volume":"364","author":"Lux","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejpn.2009.03.004","article-title":"Favourable prognostic factors with infantile spasms","volume":"14","author":"Riikonen","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0220","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jpeds.2006.12.004","article-title":"Developmental outcomes of cryptogenic West syndrome","volume":"150","author":"Hamano","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0225","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1528-1167.2008.01589.x","article-title":"Vigabatrin in the treatment of childhood epilepsy: A retrospective chart review of efficacy and safety profile","volume":"49","author":"Camposano","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0230","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.0013-9580.2004.30503.x","article-title":"Long term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone","volume":"45","author":"Kivity","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0235","doi-asserted-by":"crossref","first-page":"578","DOI":"10.33588\/rn.3106.2000393","article-title":"Propuesta para el tratamiento de los ni\u00f1os con s\u00edndrome de West","volume":"31","author":"Herranz","year":"2000","journal-title":"Rev Neurol"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0240","first-page":"52","article-title":"Therapeutic trial of vigabatrin in refractory infantile spasms","volume":"Suppl 2","author":"Chiron","year":"1991","journal-title":"J Child Neurol"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0245","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1528-1157.1997.tb00063.x","article-title":"Vigabatrin versus ACTH as first-line treatment for infantile spasms: A randomized, prospective study","volume":"38","author":"Vigevano","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0250","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1528-1157.1996.tb00627.x","article-title":"Vigabatrin as initial therapy for infantile spasms: A European retrospective survey. Sabril IS investigator and peer review groups","volume":"37","author":"Aicardi","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0255","first-page":"1365","article-title":"Uso de monoterapia con vigabatrina en el tratamiento del s\u00edndrome de West","volume":"25","author":"Rufo","year":"1997","journal-title":"Rev Neurol"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0260","first-page":"102","article-title":"First-line monotherapy with vigabatrin in infantile spasms: Long-term clinical and EEG evolution in 12 patients","volume":"36","author":"Buti","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0265","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1528-1157.1999.tb00802.x","article-title":"Treatment of infantile spasms: Results of a population-based study with vigabatrin as the first drug for spasms","volume":"40","author":"Granstrom","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0270","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.ophtha.2004.03.036","article-title":"Characteristic retinal atrophy with secondary \u201cinverse\u201d optic atrophy identifies vigabatrin toxicity in children","volume":"111","author":"Buncic","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0275","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1212\/01.WNL.0000098938.80082.25","article-title":"Peripheral retinal dysfunction in patients taking vigabatrin","volume":"61","author":"McDonagh","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0280","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1345\/aph.1R535","article-title":"Adrenocorticotropic hormone for the treatment of west syndrome in children","volume":"47","author":"Shumiloff","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0285","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1212\/01.WNL.0000127773.72699.C8","article-title":"Practice parameter: Medical treatment of infantile spasms. Report of the American Academy of Neurology and the Child Neurology Society","volume":"62","author":"Mackay","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0290","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/j.1528-1167.2006.00888.x","article-title":"The risk of lower mental outcome in infantile spasms increases after three weeks of hypsarrhythmia duration","volume":"47","author":"Rener-Primec","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0295","doi-asserted-by":"crossref","first-page":"42","DOI":"10.15844\/pedneurbriefs-29-6-1","article-title":"Investigations in West syndrome: Which, when and why","volume":"26","author":"Appleton","year":"2015","journal-title":"Pediatr Neurol Briefs"},{"key":"10.1016\/j.anpedi.2017.10.012_bib0300","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1093\/hmg\/ddu199","article-title":"The genetic landscape of infantile spasms","volume":"23","author":"Michaud","year":"2014","journal-title":"Hum Mol Genet"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403317304526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403317304526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T07:22:40Z","timestamp":1751095360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403317304526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1695403317304526"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2017.10.012","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S\u00edndrome de West criptog\u00e9nico: perfil cl\u00ednico, respuesta al tratamiento y factores pron\u00f3sticos","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2017.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}